Chemotherapy for breast cancer Doctors Abroad — Page 2

Dr. Ahmet Belici is an experienced medical oncologist with 20+ years of experience specializing in sarcoma and lung cancer treatments.

Dr. Ozcan Yildiz is an oncologist and hematologist at Medipol Mega University Hospital in Istanbul. He specializes in treating complex neuroendocrine tumors and gynecological cancers. Dr. Yildiz has published numerous studies in prestigious journals like Medical Oncology and International Journal of Cardiology. He works at a JCI-accredited facility recognized for its bone marrow transplant expertise.

• Expertise in treating lung, breast, and gastrointestinal cancers.
• Treats hematological conditions including idiopathic thrombocytopenia.
• Published research on thyroid therapy and steroid synthesis safety.
• Performs specialized procedures like leukemia chemotherapy and tumor biopsies.

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Professor Cemil Bilir is a highly qualified medical oncologist at VM Medical Park Pendik who is currently pursuing a PhD in inorganic chemistry to deepen his expertise in treatment formulations.

• Completed a research fellowship at Northeastern University's Center for Pharmaceutical Biotechnology and Nanomedicine in Boston
• Published extensive research on medical oncology during his tenure as a Professor at Sakarya University
• Gained international clinical experience through a rotation at the world-leading Cleveland Clinic
• Holds active memberships in the European Society for Medical Oncology and the American Society of Clinical Oncology

Dr. Baha Zengel is a general surgeon with expertise in breast, gallbladder, thyroid diseases, and hernia repairs. He graduated from Ege University Faculty of Medicine in 1990. In 2004, he earned a doctorate in Basic Oncology from Dokuz Eylül University. He became an Associate Professor of General Surgery in 2014 through the Inter-University Board.

Dr. Zengel is skilled in advanced surgical procedures. His experience includes skin and breast-conserving mastectomy, oncoplastic breast surgery, laparoscopic cholecystectomy, sentinel lymph node biopsy, and ROLL/SNOLL techniques. He has held important positions at Izmir Bozyaka Training and Research Hospital, including Education Officer.

He is a member of several professional associations. He serves on the Board of Directors of the Aegean Region Surgery Association and is a founding board member of the Basic Oncology Association.

Professor Mustafa Serkan Alemdar is a medical oncology specialist at Medical Park Antalya with deep roots in university-level clinical research.

• Specialised in medical oncology at Akdeniz University Faculty of Medicine
• Completed dual specialisations in both internal medicine and medical oncology
• Served at Akdeniz University Hospital for over a decade across various roles
• Practises at Medical Park Antalya Hospital Complex – a major JCI-accredited facility

Professor Ercan Ozden is a specialist in medical oncology who completed his advanced subspecialty training at the Kocaeli University Faculty of Medicine.

• Specialised in medical oncology and internal medicine at Istanbul University's renowned Cerrahpaşa Faculty
• Practises at VM Medical Park Pendik Hospital – a major multidisciplinary medical centre
• Focuses on tailoring chemotherapy protocols for breast cancer patients
• Member of the Turkish Society of Medical Oncology

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital Topkapı, specialising in tailormade chemotherapy protocols for complex breast cancer cases.

• Expert in managing high-risk breast cancer based on BRCA genetic mutation profiles
• Specialises in adjuvant capecitabine therapy for patients with residual triple-negative breast cancer
• Published researcher on the impact of metabolic tumour volume on chemotherapy response
• Active member of the American Society of Clinical Oncology (ASCO)
• Education Coordinator for Medical Oncology at one of Turkey's major training hospitals

Professor Irfan Cicin is a senior medical oncologist who leads cancer care at İstinye University Liv Hospital Topkapı. He holds a professorship at Trakya University, where he trains the next generation of cancer specialists.

• Completed specialist oncology fellowship at Trakya University Faculty of Medicine
• Experienced in managing complex internal medicine cases alongside chemotherapy
• Served as a physician for the Turkish Air Force Command
• Former lead oncologist at Elazığ Training and Research Hospital
• Expertise covers a broad range of hard-to-treat solid tumours

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acibadem District Hospital, specialising in neoadjuvant chemotherapy and targeted therapies for breast cancer.

• Published over 50 scientific articles focusing on treatment responses and patient prognosis
• Expert in managing cancer-related malnutrition and cachexia to support patients during intensive chemotherapy
• Serves on the editorial board of BMC Cancer, a major international medical journal
• Member of the European Society for Medical Oncology (ESMO)
• Completed a clinical observership at the University of Leicester in the United Kingdom

Associate Professor Ayse Irem Yasin is a highly qualified medical oncologist who completed a targeted international observership at Italy's Maggiore della Carita Hospital Breast Cancer Unit.

• Holds a European Society for Medical Oncology (ESMO) Board Certification
• Gained specialist clinical experience at Cleveland Clinic and Harvard Medical School
• Specialises in managing complex systemic therapies for breast and gynaecological cancers
• Academically recognised as an Associate Professor for her contributions to oncology
• Practises at Medipol Acibadem District Hospital in Istanbul

Associate Professor Nail Paksoy is a Board Certified medical oncologist who has served as a sub-investigator on high-profile international clinical trials for Roche and AstraZeneca.

• Specialises in chemotherapy for HER2-positive and BRCA-mutated breast cancers
• Holds European Society for Medical Oncology (ESMO) Board Certification
• Expert in treating metastatic cases and managing late-stage disease recurrence
• Extensively published in journals like Scientific Reports on long-term breast cancer outcomes
• Member of the Turkish Oncology Group with deep expertise in targeted drug therapies